Stem cell therapy holds promise as a novel approach to address Graves' disease, an autoimmune disorder affecting the thyroid gland. In this therapy, mesenchymal stem cells, often derived from the patient's own adipose tissue or bone marrow, are employed to modulate the immune system and mitigate the overactive thyroid function associated with Graves' disease.

Research suggests that mesenchymal stem cells possess immunomodulatory properties, influencing the immune response to curb autoimmune reactions. By introducing these cells into the body, the goal is to suppress the immune system's attack on the thyroid, reducing inflammation and preventing further damage to the gland.

While the field of stem cell therapy for Graves' disease is still in its early stages, preliminary studies and clinical trials show encouraging results. The potential to address the root cause of autoimmune conditions by modifying immune responses underscores the significance of stem cells in offering alternative treatment avenues.